3 Generic Drug Antitrust Deals Totaling $17.9M Get Final Nod

A Connecticut federal judge on Wednesday gave final approval to a $17.9 million generic drug price-fixing settlement between pharmaceutical companies Bausch Health US LLC, Bausch Health Americas Inc., and Lannett Co....

Already a subscriber? Click here to view full article